CHITOFUN BIOTECH AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: EE
Ellen Elisabeth Altenborg1967
Chairman of the board: AK
Achim Kohler1967
Years since formation: 2 years; since May 22, 2023
Type: Limited company
VAT registered: No
Number of employees: 0

Ownership

Number of shares and share classes: 30,000; 1 share class
Total number of shareholders: 4; 1 company, 3 persons

Financials

Annual total result 2023: -8,256; NOK
Total equity 2023: 21,744; NOK

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
EE Ellen Elisabeth Altenborg 1967	Managing Director/CEO	12.5 % indirectly

Board

Name	Role	Shares
AK Achim Kohler 1967	Chairman	25 % directly

Top 10 individual shareholders

Name	Role	Shares
AK Achim Kohler 1967	Chairman	25 % directly
VS Volha Shapaval 1982	-	25 % directly
EE Ellen Elisabeth Altenborg 1967	Managing Director/CEO	12.5 % indirectly
KL Kjetil Fladmark Larsen 1964	-	12.5 % indirectly

Last update: May 22, 2023

Ownership

Company shareholders

Name	Share class	Number of shares	Share
L LINKE INVEST & MANAGEMENT AS	Ordinary shares	7,500	25 %
AK Achim Kohler 1967	Ordinary shares	7,500	25 %
SD Simona Dzurendova	Ordinary shares	7,500	25 %
VS Volha Shapaval 1982	Ordinary shares	7,500	25 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2023
Total operating income	0
Annual Total Result	-8,256
Total assets	21,744
Total liabilities	0
Total equity	21,744

P&L

Year	2023
Total operating income	0
Total operating costs	8,263
Operating result	-8,263
Financial income/costs	7
Profit before tax	-8,256
Total tax & extraordinary income/cost	0
Annual Total Result	-8,256

Balance overview

Year	2023
Total fixed assets	0
Total current assets	21,744
Total assets	21,744
Short term debt	0
Long term debt	0
Total liabilities	0
Contributed capital	30,000
Retained earnings	-8,256
Total equity	21,744
Total equity and liabilities	21,744

CHITOFUN BIOTECH AS931 424 742